Twitter LinkedIn YouTube iTune Podcast Google Podcasts Spotify

Predictmedix Inc. OTCQB: PMEDF

InvestorIntel Features on Predictmedix Inc.

Predictmedix Inc. Announces a Major North American Sales Contract with Juiceworks Exhibits for its COVID-19 Mass Screening Technology

May 20, 2020 (Source) – Predictmedix announces its first significant North American sales contract Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the […]

Predictmedix’s Dr. Kushwah on how AI technology for mass screening of COVID-19 is here

“We have developed a technology to screening for COVID-19 and the key is, it is a mass screening technology. The […]

Predictmedix Inc. Announces Appointment of Microsoft Director of Business Development for AI Solutions as the Chairman of the Advisory Board

May 12, 2020 (Source) – Predictmedix Bolsters its Advisory Board with Key Technology Director Kapil Raval Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) […]

Company Overview


Predictmedix Inc. is an artificial intelligence (“AI”) company developing disruptive and cutting-edge tools for impairment testing and healthcare. It is intended that the Company’s cannabis and alcohol impairment detection tools will be used across various workplaces and by law enforcement agents. Its technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. Testing does not require any body fluids or human intervention, thereby helping to remove human error and the potential for discrimination and prejudice. The Company has partnered with Tech Mahindra and Hindalco to help expedite the launch of its impairment technology, as well as the prestigious Indian Institute of Technology.

News Releases

Twitter LinkedIn YouTube Amazon Alexa iTune Podcast Google Podcasts Spotify